Candida glabrata: A deadly companion?

Yeast

Volumn 31, Issue 8, 2014, Pages 279-288

  Bolotin Fukuhara, Monique ^a   Fairhead, Cécile ^a  

^a INSTITUTE FOR INTEGRATIVE BIOLOGY OF THE CELL I2BC   (France)

Author keywords

Asexual species; Candida; Fungal pathogen; Yeast

Indexed keywords

CARBON;

ARTICLE; CANDIDA GLABRATA; CARBON METABOLISM; FUNGAL GENOME; FUNGAL MATING TYPE GENE; FUNGAL VIRULENCE; GENE SWITCHING; HISTORY; MATING; NAKASEOMYCES; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; ADAPTATION; CANDIDIASIS; CLASSIFICATION; GENETICS; HUMAN; IMMUNOCOMPROMISED PATIENT; ISOLATION AND PURIFICATION; MICROBIOLOGY; PHYLOGENY; PHYSIOLOGY; VIRULENCE;

CANDIDA; CANDIDA ALBICANS; CANDIDA GLABRATA; SACCHAROMYCES CEREVISIAE; SACCHAROMYCETACEAE;

ADAPTATION, BIOLOGICAL; CANDIDA GLABRATA; CANDIDIASIS; HUMANS; IMMUNOCOMPROMISED HOST; PHYLOGENY; VIRULENCE;

EID: 84905494926     PISSN: 0749503X     EISSN: 10970061     Source Type: Journal    
DOI: 10.1002/yea.3019     Document Type: Article

References (92)

1. Alcoba-Florez J, Mendez-Alvarez S, Cano J, et al. 2005. Phenotypic and molecular characterization of Candida nivariensis sp. nov., a possible new opportunistic fungus. J Clin Microbiol 43(8): 4107-4111.
2. Anderson HW. 1917. Yeast-like fungi of the human intestinal tract. J Infect Dis 21: 341-385.
3. Arendrup MC, Fuursted K, Gahrn-Hansen B, et al. 2008. Semi-national surveillance of fungaemia in Denmark 2004-2006: increasing incidence of fungaemia and numbers of isolates with reduced azole susceptibility. Clin Microbiol Infect 14(5): 487-494.
4. Atanasova R, Angoulvant A, Tefit M, et al. 2013. A mouse model for Candida glabrata hematogenous disseminated infection starting from the gut: evaluation of strains with different adhesion properties. PLoS One 8(7): e69664.
5. Bakhrat A, Jurica MS, Stoddard BL, Raveh D. 2004. Homology modeling and mutational analysis of Ho endonuclease of yeast. Genetics 166(2): 721-728.
6. Bernstein H, Byerly HC, Hopf FA, Michod RE. 1985. Genetic damage, mutation, and the evolution of sex. Science 229(4719): 1277-1281.
7. Bouchara JP, Zouhair R, Le Boudouil S, et al. 2000. In vivo selection of an azole-resistant petite mutant of Candida glabrata. J Med Microbiol 49(11): 977-984.
8. Bouchier C, Ma L, Créno S, et al. 2009. Complete mitochondrial genome sequences of three Nakaseomyces species reveal invasion by palindromic GC clusters and considerable size expansion. FEMS Yeast Res 9(8): 1283-1292.
9. Brockert PJ, Lachke SA, Srikantha T, et al. 2003. Phenotypic switching and mating type switching of Candida glabrata at sites of colonization. Infect Immun 71(12): 7109-7118.
10. Brown CA, Murray AW, Verstrepen KJ. 2010. Rapid expansion and functional divergence of subtelomeric gene families in yeasts. Curr Biol 20(10): 895-903.
11. Brun S, Bergès T, Poupard P, et al. 2004. Mechanisms of azole resistance in petite mutants of Candida glabrata. Antimicrob Agents Chemother 48(5): 1788-1796.
12. Brun S, Dalle F, Saulnier P, et al. 2005. Biological consequences of petite mutations in Candida glabrata. J Antimicrob Chemother 56(2): 307-314.
13. Butler G, Kenny C, Fagan A, et al. 2004. Evolution of the MAT locus and its Ho endonuclease in yeast species. Proc Natl Acad Sci U S A 101(6): 1632-1637.
14. Calcagno AM, Bignell E, Warn P, et al. 2003. Candida glabrata STE12 is required for wild-type levels of virulence and nitrogen starvation induced filamentation. Mol Microbiol 50(4): 1309-1318.
15. Calcagno AM, Bignell E, Rogers TR, et al. 2004. Candida glabrata Ste20 is involved in maintaining cell wall integrity and adaptation to hypertonic stress, and is required for wild-type levels of virulence. Yeast 21(7): 557-568.
16. Cormack BP, Ghori N, Falkow S. 1999. An adhesin of the yeast pathogen Candida glabrata mediating adherence to human epithelial cells. Science 285: 578-582.
17. Correia A, Sampaio P, James S, Pais C. 2006. Candida bracarensis sp. nov., a novel anamorphic yeast species phenotypically similar to Candida glabrata. Int J Systemat Evol Microbiol 56(1): 313-317.
18. Defontaine A, Bouchara JP, Declerk P, et al. 1999. In vitro resistance to azoles associated with mitochondrial DNA deficiency in Candida glabrata. J Med Microbiol 48(7): 663-670.
19. De Groot PW, Kraneveld EA, Yin QY, et al. 2008. The cell wall of the human pathogen Candida glabrata: differential incorporation of novel adhesin-like wall proteins. Eukaryot Cell 7(11): 1951-1964.
20. De Las Peñas A, Pan SJ, Castaño I, et al. 2003. Virulence-related surface glycoproteins in the yeast pathogen Candida glabrata are encoded in subtelomeric clusters and subject to RAP1- and SIR-dependent transcriptional silencing. Genes Dev 17(18): 2245-2258.
21. Desai C, Mavrianos J, Chauhan N. 2011. Candida glabrata Pwp7p and Aed1p are required for adherence to human endothelial cells. FEMS Yeast Res 11(7): 595-601.
22. Dodgson AR, Pujol C, Denning DW, et al. 2003. Multilocus sequence typing of Candida glabrata reveals geographically enriched clades. J Clin Microbiol 41(12): 5709-5717.
23. Dodgson AR, Pujol C, Pfaller MA, et al. 2005. Evidence for recombination in Candida glabrata. Fungal Genet Biol 42(3): 233-243.
24. Domergue R, Castaño I, De Las Peñas A, et al. 2005. Nicotinic acid limitation regulates silencing of Candida adhesins during UTI. Science 308(5723): 866-870.
25. Dujon B, Sherman D, Fischer G, et al. 2004. Genome evolution in yeasts. Nature 430(6995): 35-44.
26. Edskes HK, Wickner RB. 2013. The URE3 prion in Candida. Eukaryot Cell 12(4): 551-558.
27. Fabre E, Muller H, Therizols P, et al. 2005. Comparative genomics in hemiascomycete yeasts: evolution of sex, silencing, and subtelomeres. Mol Biol Evol 22(4): 856-873.
28. Ferrari S, Sanguinetti M, De Bernardis F, et al. 2011. Loss of mitochondrial functions associated with azole resistance in Candida glabrata results in enhanced virulence in mice. Antimicrob Agents Chemother 55(5): 1852-1860.
29. Fidel PL, Vazquez JA, Sobel JD. 1999. Candida glabrata: review of epidemiology, pathogenesis, and clinical disease with comparison to C. albicans. Clin Microbiol Rev 12: 80-96.
30. Freese S, Vogts T, Speer F, et al. 2011. C- and N-catabolic utilization of tricarboxylic acid cycle-related amino acids by Scheffersomyces stipitis and other yeasts. Yeast 28(5): 375-390.
31. Gabaldón T, Martin T, Marcet-Houben M, et al. 2013. Comparative genomics of emerging pathogens in the Candida glabrata clade. BMC Genom 14(1): 623.
32. Gallegos-García V, Pan SJ, Juárez-Cepeda J, et al. 2012. A novel downstream regulatory element cooperates with the silencing machinery to repress EPA1 expression in Candida glabrata. Genetics 190(4): 1285-1297.
33. Gordon JL, Armisén D, Proux-Wéra E, et al. 2011. Evolutionary erosion of yeast sex chromosomes by mating-type switching accidents. Proc Natl Acad Sci U S A 108(50): 20024-20029.
34. O'Gorman CM, Fuller H, Dyer PS. 2009. Discovery of a sexual cycle in the opportunistic fungal pathogen Aspergillus fumigatus. Nature 457(7228): 471-474.
35. Hagman A, Säll T, Compagno C, et al. 2013. Yeast 'make-accumulate-consume' life strategy evolved as a multi-step process that predates the whole genome duplication. PLoS One 8(7): e68734.
36. Halliwell SC, Smith MC, Muston P, et al. 2012. Heterogeneous expression of the virulence-related adhesin Epa1 between individual cells and strains of the pathogen Candida glabrata. Eukaryot Cell 11(2): 141-150.
37. Hazen KC. 1995. New and emerging yeast pathogens. Clin Microbiol Rev 8(4): 462-478.
38. Hickman MA, Zeng G, Forche A, et al. 2013. The 'obligate diploid' C. albicans forms mating-competent haploids. Nature 494(7435): 55-59.
39. Horn DL, Neofytos D, Anaissie EJ, et al. 2009. Epidemiology and outcomes of candidemia in 2019 patients: data from the prospective antifungal therapy alliance registry. Clin Infect Dis 48(12): 1695-1703.
40. Hull CM, Raisner RM, Johnson AD. 2000. Evidence for mating of the 'asexual' yeast Candida albicans in a mammalian host. Science 289(5477): 307-310.
41. Jawhara S, Mogensen E, Maggiotto F, et al. 2012. Murine model of dextran sulfate sodium-induced colitis reveals Candida glabrata virulence and contribution of β-mannosyltransferases. J Biol Chem 287(14): 11313-11324.
42. Just G, Steinheimer D, Schnellbach M, et al. 1989. Change of causative organisms under antifungal treatment in immunosuppressed patients with HIV infections. Mycoses 32(suppl 2): 47-51.
43. Kamran M, Calcagno AM, Findon H, et al. 2004. Inactivation of transcription factor gene ACE2 in the fungal pathogen Candida glabrata results in hypervirulence. Eukaryot Cell 3(2): 546-552.
44. Katz Ezov T, Chang SL, Frenkel Z, et al. 2010. Heterothallism in Saccharomyces cerevisiae isolates from nature: effect of HO locus on the mode of reproduction. Mol Ecol 19(1): 121-131.
45. Kaur R, Ma B, Cormack BP. 2007. A family of glycosylphosphatidylinositol-linked aspartyl proteases is required for virulence of Candida glabrata. Proc Natl Acad Sci USA 104(18): 7628-7633.
46. Kerwin CL, Wykoff DD. 2012. De novo generation of a phosphate starvation-regulated promoter in Candida glabrata. FEMS Yeast Res 12(8): 980-989.
47. Kitamura A, Higuchi S, Hata M, et al. 2009. Effect of β-1, 6-glucan inhibitors on the invasion process of Candida albicans: potential mechanism of their in vivo efficacy. Antimicrob Agents Chemother 53(9): 3963-3971.
48. Kraneveld EA, de Soet JJ, Deng DM, et al. 2011. Identification and differential gene expression of adhesin-like wall proteins in Candida glabrata biofilms. Mycopathologia 172(6): 415-427.
49. Kontoyiannis DP. 2000. Modulation of fluconazole sensitivity by the interaction of mitochondria and erg3 in S. cerevisiae. J Antimicrob Chemother 46(2): 191-197.
50. Koszul R, Malpertuy A, Frangeul L, et al. 2003. The complete mitochondrial genome sequence of the pathogenic yeast Candida (Torulopsis) glabrata. FEBS Lett 34: 39-48.
51. Kurtzman CP. 2003. Phylogenetic circumscription of Saccharomyces, Kluyveromyces and other members of the Saccharomycetaceae, and the proposal of the new genera Lachancea, Nakaseomyces, Naumovia, Vanderwaltozyma and Zygotorulaspora. FEMS Yeast Res 4(3): 233-245.
52. Kurtzman CP, Fell JW, Boekhout T (eds). 2011. The Yeasts, A Taxonomic Study, 5th edn. Elsevier: London.
53. Kurtzman CP, Robnett CJ. 1998. Identification and phylogeny of ascomycetous yeasts from analysis of nuclear large subunit (26S) ribosomal DNA partial sequences. Antonie Van Leeuwenhoek 73: 331-371.
54. Li S, Chen X, Liu L, Chen J. 2013. Pyruvate production in Candida glabrata: manipulation and optimization of physiological function. Crit Rev Biotechnol. DOI: 10.3109/07388551.2013.811636
55. Lin CY, Chen YC, Lo HJ, et al. 2007. Assessment of Candida glabrata strain relatedness by pulsed-field gel electrophoresis and multilocus sequence typing. J Clin Microbiol 45(8): 2452-2459.
56. Loureiro Y, Penha CV, Kubitschek PH, et al. 2010. Proteomic analysis of cytosolic proteins associated with petite mutations in Candida glabrata. Braz J Med Biol Res 43(12): 1203-1014.
57. MacCallum DM. 2012. Hosting infection: experimental models to assay Candida virulence. Int J Microbiol 2012: 363764.
58. Maestre-Reyna M, Diderrich R, Veelders MS, et al. 2012. Structural basis for promiscuity and specificity during Candida glabrata invasion of host epithelia. Proc Natl Acad Sci U S A 109: 16864-16869.
59. Magee BB, Magee PT. 2000. Induction of mating in Candida albicans by construction of MTLa and MTLα strains. Science 289: 310-313.
60. Mehra RK, Thorvaldsen JL, Macreadie IG, Winge DR. 1992. Cloning system for Candida glabrata using elements from the metallothionein IIa-encoding gene that confer autonomous replication. Gene 113(1): 119-124.
61. Merico A, Sulo P, Piskur J, Compagno C. 2007. Fermentative lifestyle in yeasts belonging to the Saccharomyces complex. FEBS J 274(4): 976-989.
62. Miyazaki T, Yamauchi S, Inamine T, et al. 2010a. Roles of calcineurin and Crz1 in antifungal susceptibility and virulence of Candida glabrata. Antimicrob Agents Chemother 54(4): 1639-1643.
63. Miyazaki T, Inamine T, Yamauchi S, et al. 2010b. Role of the Slt2 mitogen-activated protein kinase pathway in cell wall integrity and virulence in Candida glabrata. FEMS Yeast Res 10(3): 343-352.
64. Muller H, Hennequin C, Gallaud J, et al. 2008. The asexual yeast C. glabrata maintains distinct a and α haploid mating types. Eukaryot Cell 7(5): 848-858.
65. Nielsen K, Heitman J. 2007. Sex and virulence of human pathogenic fungi. Adv Genet 57: 143-173.
66. Otto V, Howard DH. 1976. Further studies on the intracellular behavior of Torulopsis glabrata. Infect Immun 14(2): 433-438.
67. Palma M, Seret ML, Baret PV. 2009. Combined phylogenetic and neighbourhood analysis of the hexose transporters and glucose sensors in yeasts. FEMS Yeast Res 9(4): 526-534.
68. Pfaller MA. 2012. Antifungal drug resistance: mechanisms, epidemiology, and consequences for treatment. Am J Med 125(supp 1): S3-13.
69. Piens MA, Perry JD, Raberin H, et al. 2003. Routine use of a one minute trehalase and maltase test for the identification of Candida glabrata in four laboratories. J Clin Pathol 56(9): 687-689.
70. Rai MN, Balusu S, Gorityala N, et al. 2012. Functional genomic analysis of Candida glabrata-macrophage interaction: role of chromatin remodeling in virulence. PLoS Pathog 8(8): e1002863.
71. Rice WR. 2002. Experimental tests of the adaptive significance of sexual recombination. Nat Rev Genet 3(4): 241-251.
72. Roetzer A, Gabaldón T, Schüller C. 2011. From Saccharomyces cerevisiae to Candida glabrata in a few easy steps: important adaptations for an opportunistic pathogen. FEMS Microbiol Lett 314(1): 1-9.
73. Roetzer A, Gratz N, Kovarik P, Schuller C. 2010. Autophagy supports Candida glabrata survival during phagocytosis. Cell Microbiol 12: 199-216.
74. Saijo T, Miyazaki T, Izumikawa K, et al. 2010. Skn7p is involved in oxidative stress response and virulence of Candida glabrata. Mycopathologia 169(2): 81-90.
75. Sanglard D, Ischer F, Bille J. 2001. Role of ATP-binding-cassette transporter genes in high-frequency acquisition of resistance to azole anti-fungals in Candida glabrata. Antimicrob Agents Chemother 45: 1174-1183.
76. Sanguinetti M, Posteraro B, Fiori B, et al. 2005. Mechanisms of azole resistance in clinical isolates of Candida glabrata collected during a hospital survey of antifungal resistance. Antimicrob Agents Chemother 49: 668-679.
77. Seider K, Brunke S, Schild L, et al. 2011. The facultative intracellular pathogen Candida glabrata subverts macrophage cytokine production and phagolysosome maturation. J Immunol 187: 3072-3086.
78. Seider K, Gerwien F, Kasper L, et al. 2014. Immune evasion, stress resistance, and efficient nutrient acquisition are crucial for intracellular survival of Candida glabrata within macrophages. Eukaryot Cell 13(1): 170-183.
79. Shingu-Vazquez M, Traven A. 2011. Mitochondria and fungal pathogenesis: drug tolerance, virulence, and potential for antifungal therapy. Eukaryot Cell 10(11): 1376-1383.
80. Srikantha T, Lachke SA, Soll DR. 2003. Three mating type-like loci in Candida glabrata. Eukaryot Cell 2(2): 328-340.
81. Thierry A, Bouchier C, Dujon B, Richard GF. 2008. Megasatellites: a peculiar class of giant minisatellites in genes involved in cell adhesion and pathogenicity in Candida glabrata. Nucleic Acids Res 36(18): 5970-5982.
82. Ueno K, Uno J, Nakayama H, et al. 2007. Development of a highly efficient gene targeting system induced by transient repression of YKU80 expression in Candida glabrata. Eukaryot Cell 6(7): 1239-1247.
83. Ueno K, Matsumoto Y, Uno J, et al. 2011. Intestinal resident yeast Candida glabrata requires Cyb2p-mediated lactate assimilation to adapt in mouse intestine. PLoS One 6(9): e24759.
84. West M, Lowman DW, Mora-Montes HM, et al. 2013. Differential virulence of Candida glabrata glycosylation mutants. J Biol Chem 288(30): 22006-22018.
85. Westermeyer C, Macreadie IG. 2007. Simvastatin reduces ergosterol levels, inhibits growth and causes loss of mtDNA in Candida glabrata. FEMS Yeast Res 7(3): 436-441.
86. Whelan WL, Kwon-Chung KJ. 1987. Parasexual genetics of Torulopsis glabrata. J Bacteriol 169(11): 4991-4994.
87. Wong S, Fares MA, Zimmermann W, et al. 2003. Evidence from comparative genomics for a complete sexual cycle in the 'asexual' pathogenic yeast Candida glabrata. Genome Biol 4(2): R10.
88. Yang S, Chen X, Xu N, et al. 2014. Urea enhances cell growth and pyruvate production in Torulopsis glabrata. Biotechnol Progr 30: 19-27.
89. Zavel M, Hoot SJ, White TC. 2013. Comparison of sterol import under aerobic and anaerobic conditions in three fungal species, Candida albicans, Candida glabrata, and Saccharomyces cerevisiae. Eukaryot Cell 12(5): 725-738.
90. Zordan RE, Ren Y, Pan SJ, et al. 2013. Expression plasmids for use in Candida glabrata. G3 (Bethesda) 3(10): 1675-1686.
91. Zhou P, Szczypka MS, Young R, Thiele DJ. 1994. A system for gene cloning and manipulation in the yeast Candida glabrata. Gene 142(1): 135-140.
92. Zhou J, Liu L, Chen J. 2010. Mitochondrial DNA heteroplasmy in C. glabrata after mitochondrial transformation. Eukaryot Cell 9(5): 806-814.